anti-LeY- scFv-CD28-ζ vector / Peter MacCallum Cancer Centre, BMS - LARVOL DELTA

A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours (clinicaltrials.gov) - P1 | N=20 | Completed | Sponsor: Peter MacCallum Cancer Centre, Australia | Active, not recruiting ➔ Completed

CAR T-Cell Therapy • Metastases • Trial completion • Hematological Malignancies • Oncology • Solid Tumor

A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours (clinicaltrials.gov) - P1 | N=20 | Completed | Sponsor: Peter MacCallum Cancer Centre, Australia | Active, not recruiting ➔ Completed | Trial completion date: Dec 2024 ➔ Apr 2022 | Trial primary completion date: Apr 2021 ➔ Apr 2022

CAR T-Cell Therapy • Trial completion • Trial completion date • Trial primary completion date • Hematological Malignancies • Immunology • Oncology • Solid Tumor

A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours (clinicaltrials.gov) - P1; N=21; Active, not recruiting; Sponsor: Peter MacCallum Cancer Centre, Australia; Recruiting ➔ Active, not recruiting; N=30 ➔ 21; Trial primary completion date: Dec 2019 ➔ Apr 2021

Clinical • Enrollment change • Enrollment closed • Trial primary completion date • Hematological Malignancies • Immunology • Oncology • Solid Tumor

A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours (clinicaltrials.gov) - P1; N=30; Recruiting; Sponsor: Peter MacCallum Cancer Centre, Australia

Clinical • New P1 trial